R.U. Wahl - Concepedia

Author

R.U. Wahl

RWTH Aachen University ORCID

Also Known As

R Wahl, R. U. Wahl, R. Wahl, R.U. Wahl, Renate U. Wahl, Renate Ursula Wahl, Renate Wahl

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

RWTH Aachen University Friedrich-Alexander-Universität Erlangen-Nürnberg German Cancer Research Center Universitätsklinikum Erlangen Universitätsklinikum Aachen

About

R.U. Wahl is an author at RWTH Aachen University specializing in medicine, tumor biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.3K
2	Health Sciences	1	1	50
3	Cell Biology	1	1	50
4	Hepatology	1	1	638
5	Immunology	1	1	20

R.U. Wahl

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy Lars Hofmann, Andrea Forschner, Carmen Loquai, European Journal of Cancer UrologyHepatologyAnti-pd-1 TherapyGastrointestinal PharmacologyLiver Physiology	2016	638
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy Lisa Zimmer, Simone M. Goldinger, Lars Hofmann, European Journal of Cancer Translational MedicineHeart FailureCardiovascular DiseaseAnti-pd-1 TherapyMedicine	2016	552
Melanoma stem cell maintenance and chemo-resistance are mediated by CD133 signal to PI3K-dependent pathways Siraj M. El Jamal, Abdulhadi A. AlAmodi, R.U. Wahl, Oncogene Cell RegulationMedicineStem CellsMelanomaPi3k-dependent Pathways	2020	50
Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real‐world conditions in Germany – The non‐interventional study NIELS Ralf Gutzmer, H. J. Schulze, Axel Hauschild, Journal of the European Academy of Dermatology and Venereology	2021	21
Correlative Monitoring of Immune Activation and Tissue Damage in Malignant Melanoma—An Algorithm for Identification of Tolerance Breakage During Immune Checkpoint Inhibitor Therapy of Cancer R.U. Wahl, Marike M. Leijs, Arturo Araujo, International Journal of Molecular Sciences Immune ActivationImmunologyPathologyTolerance BreakageImmunotherapeutics	2020	20
Mutation analysis of multiple pilomatricomas in a patient with myotonic dystrophy type 1 suggests a DM1-associated hypermutation phenotype Albert Rübben, R.U. Wahl, Thomas Eggermann, PLoS ONE Cancer PathologyGeneticsPathologyDm1-associated Hypermutation PhenotypeDmpk Gene	2020	19
Immunotherapy with Imiquimod and Interferon Alfa for Metastasized Merkel Cell Carcinoma R.U. Wahl, Till Braunschweig, Alireza Ghassemi, Current Oncology	2016	13
Cutaneous Basal Cell Carcinoma with Lymph Node and Pulmonary Metastases R.U. Wahl, Claudio Cacchi, Albert Rübben Case Reports in Oncological Medicine Sonic Hedgehog BlockadeMedicineSurgical PathologyPulmonary MetastasesPathology	2018	10

Page 1